JAKARTA – PT Enseval Putera Megatrading Tbk (EPMT), a healthcare devices seller and distributor, projected its revenue in 2022 to grow 10% from the projection of the revenue realisation this year, which might arrive at IDR 24.79 trillion.
Sugianto, Corporate Secretary of Enseval Putera Megatrading, said that the projection of sales until this Q4 2021 showed 11%-13% growth, while the sales projection in 2022 would have 10%-12% growth. “The management would always implement strategic measures to attain sustainable growth in the next years,” he said in a public expose quoted Thursday (16/12).
Up until Q3 2021, EPMT recorded revenue of IDR 18.81 trillion, climbing from the same period last year of IDR 16.86 trillion. Then, by the end of December 2020, the sales reached IDR 22.54 trillion. With the projection of 11% revenue growth by the end of this year, EPMT is projected to score IDR 24.79 trillion in sales. Furthermore, using the revenue growth rate projection in 2022 of 10%, then the company might collect sales worth IDR 27.27 trillion.
EPMT’s performance has shown a positive trend. For instance, in September 2020, EPMT recorded a gross profit of IDR 1.7 trillion, which rose to IDR 2.18 trillion in September 2021. Its operating profit also shifted from IDR 527.62 billion to IDR 809.91 billion, while its current year’s profit climbed from IDR 437.74 billion to IDR 670.06 billion. (LK/ZH)